Adlai Nortye (NASDAQ:ANL – Get Free Report) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday.
ANL has been the subject of a number of other reports. JonesTrading began coverage on shares of Adlai Nortye in a research note on Thursday, May 14th. They set a “buy” rating and a $22.00 price target for the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Adlai Nortye in a research note on Tuesday, July 14th. Cantor Fitzgerald assumed coverage on Adlai Nortye in a research report on Monday, June 22nd. They set an “overweight” rating for the company. Finally, Oppenheimer assumed coverage on shares of Adlai Nortye in a research report on Thursday, May 28th. They set an “outperform” rating and a $32.00 target price on the stock. Five analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.25.
Read Our Latest Research Report on Adlai Nortye
Adlai Nortye Stock Performance
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of ANL. SmartHarvest Portfolios LLC increased its position in Adlai Nortye by 8.5% during the 1st quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock valued at $113,000 after buying an additional 1,279 shares in the last quarter. Renaissance Technologies LLC acquired a new stake in Adlai Nortye in the first quarter worth about $457,000. ADAR1 Capital Management LLC acquired a new stake in Adlai Nortye in the first quarter worth about $816,000. Affinity Asset Advisors LLC purchased a new stake in shares of Adlai Nortye during the first quarter worth about $1,140,000. Finally, Seven Fleet Capital Management LP acquired a new position in shares of Adlai Nortye during the second quarter valued at about $1,302,000. Institutional investors own 35.21% of the company’s stock.
About Adlai Nortye
Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.
Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.
The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.
Read More
- Five stocks we like better than Adlai Nortye
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Adlai Nortye Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye and related companies with MarketBeat.com's FREE daily email newsletter.
